Evidence map

ReviewLife (Basel, Switzerland)2026

New Treatment Options for MASLD Patients with Type 2 Diabetes.

Andrea Mega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41752891